Open-Label Tolvaptan Study in Subjects With ADPKD

Mise à jour : Il y a 4 ans
Référence : NCT01214421

Femme et Homme

Extrait

To demonstrate whether tolvaptan modifies ADPKD progression as measured by changes from baseline (from trial 156-04-251) in total kidney volume (TKV) and renal function.


Critère d'inclusion

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)


Liens